Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yoe Chong Chang | M | 58 |
University of Warwick
| 5 Jahre |
| John Russell Fotheringham Walls | M | 80 |
Delphic Diagnostics Ltd.
 Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | - |
| Chin Ching Cheung | M | 60 |
University of Warwick
| 4 Jahre |
| Philip Moses | M | - |
University of Warwick
| 4 Jahre |
| Wai Man Mak | M | 60 |
University of Warwick
| 2 Jahre |
| Fathi Ridzuan bin Ahmad Fauzi | M | 60 |
University of Warwick
| 4 Jahre |
| Hing Kheong Ho | M | 56 |
University of Warwick
| 3 Jahre |
| Hock Sen Tong | M | 56 |
University of Warwick
| 3 Jahre |
| Chi Wah Fong | M | 62 |
University of Warwick
| 2 Jahre |
| Zaida Khalida binti Shaari | F | 58 |
University of Warwick
| 3 Jahre |
| Kah Sung Chow | M | 58 |
University of Warwick
| 3 Jahre |
| Mark Anthony Stone | M | - |
University of Warwick
| 4 Jahre |
| Jonathan Cruddas | M | 62 |
University of Warwick
| 3 Jahre |
| Steve Ellis | M | 61 |
University of Warwick
| 4 Jahre |
| Philip A. Curry | M | - |
University of Warwick
| 3 Jahre |
| Nonny Ugboma | F | - |
University of Warwick
| 4 Jahre |
| Sushil Patel | M | 52 |
University of Warwick
| 4 Jahre |
| Tejinder Basi | M | - |
University of Warwick
| 13 Jahre |
| Natalie Glitzenhirn-Augustin | F | - |
University of Warwick
| 4 Jahre |
| Zakiah binti Jaafar | F | 58 |
University of Warwick
| 4 Jahre |
| Andy Archer | M | - |
University of Warwick
| 3 Jahre |
| Sean King | M | - |
University of Warwick
| 3 Jahre |
| STEVE WOOSNAM | M | - |
University of Warwick
| 3 Jahre |
| Judith Yu | F | 57 |
University of Warwick
| 4 Jahre |
| Ming Chu Leung | M | 66 |
University of Warwick
| 2 Jahre |
| Mike Bagguley | M | - |
University of Warwick
| 4 Jahre |
| Paul Bennicke | M | - |
University of Warwick
| 4 Jahre |
| Michael Kerins | M | - |
University of Warwick
| 4 Jahre |
| Kevin Alan Bryett | M | - |
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | - |
| Sarah C. Gregory | F | - |
University of Warwick
| 3 Jahre |
| Steve J. Tudge | M | - |
University of Warwick
| 4 Jahre |
| Guy Davies | M | 58 |
University of Warwick
| 3 Jahre |
| Anthony Richard Booley | M | - |
University of Warwick
| 2 Jahre |
| Adrian John McDonald | M | 60 |
University of Warwick
| 4 Jahre |
| Andrew Coll | M | 54 |
University of Warwick
| 4 Jahre |
| Gary Dannatt | M | 53 |
University of Warwick
| 4 Jahre |
| David Port | M | 59 |
University of Warwick
| 4 Jahre |
| Sanjiv Karnik | M | - |
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | - |
| Idris Jala | M | 65 |
University of Warwick
| 1 Jahre |
| Patrick Gan | M | 66 |
University of Warwick
| 2 Jahre |
| Yakubu Gowon | M | - |
University of Warwick
| 3 Jahre |
| Woon-Wah Siu | F | - |
University of Warwick
| 1 Jahre |
| Anna Seddon | F | - |
University of Warwick
| 4 Jahre |
| Yiap Fook San Wee | M | 72 |
University of Warwick
| 2 Jahre |
| Alun Williams | M | - |
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | - |
| Paul Walsh | M | - |
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | - |
| David J. Back | M | - |
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | - |
| Saye H. Khoo | M | - |
Delphic Diagnostics Ltd.
Delphic Diagnostics Ltd. Medical/Nursing ServicesHealth Services Delphic is a specialist laboratory company with world-leading capabilities in pharmacology and pharmacogenetics. It was the first company in the world to offer an integrated diagnostics and biomarker service in HIV and is now applying that model in hepatitis. It has particular expertise in infectious diseases, including capabilities in study design and in method development and transfer, and a growing clinical trials portfolio. It is planning to apply its expertise to other therapy areas. Delphic is growing, organically and by acquisition, into a specialist biomarker and companion diagnostics company able to support the growing demand for personalised medicine in clinical therapy and in drug development. Its laboratories are certified to ISO, GCLP, CAP and CLIA. It has global reach via its own laboratories in the UK and partner laboratories in Italy, Spain, Greece and Argentina. | - |
| Richard Keith Palmer | M | 57 |
University of Warwick
| 4 Jahre |
| Abdulrahman Ali Saif | M | - |
University of Warwick
| 1 Jahre |
| Bernard Hilary Lawrence | M | 57 |
University of Warwick
| 3 Jahre |
| Ka Hung Law | M | 69 |
University of Warwick
| 1 Jahre |
| Eng Poh Lim | M | 56 |
University of Warwick
| 4 Jahre |
| James Campanini | M | - |
University of Warwick
| 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 54 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Tim Leaver
- Persönliches Netzwerk
